← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksAKTXPrice History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Akari Therapeutics, Plc (AKTX) Stock Price History

Historical prices from 2014 to 2026

Current Price
$0.24
-0.02 (-8.87%)
All-Time High
$934.00
Aug 20, 2015
-100.0% from ATH
All-Time Low
$0.22
Dec 18, 2025
Avg Volume (50D)
387K
Daily average
52-Week Range$0.22 — $1.73
LowCurrent: $0.24High

Loading 10-year price history...

Historical Performance

1 YearTotal Return
-72.9%
Price: -72.9%
3 YearsTotal Return
-96.6%
CAGR: -67.5%
Price: -96.6%
5 YearsTotal Return
-99.6%
CAGR: -67.7%
Price: -99.6%
YTD
-18.6%

Short-Term Returns

1D-8.9%
1W-2.8%
1M-7.0%
3M-51.4%
6M-70.7%

Download Historical Data

3,056 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

AKTX Stock Price Trajectory (2014–2026)

As of February 28, 2026, Akari Therapeutics, Plc (AKTX) trades at $0.24, representing a -72.9% return over the past year. The stock has delivered a -67.7% return over five years, reflecting challenging market conditions.

The stock reached its all-time high of $934.00 on August 20, 2015. From this peak, AKTX has corrected -100.0%, currently trading 68% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers ARGX (+22.8% 1Y), CANF (+169.9% 1Y), and ABVX (+1479.2% 1Y), AKTX has underperformed the peer group average. Compare AKTX vs ARGX →

Historical Price Data

Showing 30 of 3,056 records
Date Open High Low Close Volume Change %
2026-02-270.270.270.230.240-8.87%
2026-02-260.260.270.260.260-0.65%
2026-02-250.260.270.240.260+2.31%
2026-02-240.230.280.230.260+4.94%
2026-02-230.250.250.240.240+2.70%
2026-02-200.250.250.240.240+0.25%
2026-02-190.240.260.230.2481K-1.67%
2026-02-180.250.250.240.2484K-2.95%
2026-02-170.250.250.250.2514K+6.14%
2026-02-130.260.260.230.23135K-2.10%
2026-02-120.240.260.230.24148K-3.25%
2026-02-110.250.270.230.25230K+1.65%
2026-02-100.260.260.240.24171K-2.42%
2026-02-090.250.260.230.25130K+5.53%
2026-02-060.230.250.220.23165K+4.44%
2026-02-050.220.250.220.23272K-2.17%
2026-02-040.230.240.220.23229K-1.29%
2026-02-030.240.250.220.2385K-1.69%
2026-02-020.240.250.230.24175K+0.85%
2026-01-300.230.240.230.23104K+1.29%
2026-01-290.250.260.230.23604K-8.66%
2026-01-280.270.280.250.25426K-7.64%
2026-01-270.270.280.260.28484K+1.10%
2026-01-260.280.280.260.271.12M-0.58%
2026-01-240.280.280.250.27353K-0.15%
2026-01-230.280.280.250.27406K+2.24%
2026-01-220.250.280.250.27501K+2.68%
2026-01-210.270.270.250.26248K-1.14%
2026-01-200.270.280.260.2688K-6.05%
2026-01-160.280.290.270.28311K+5.24%

See AKTX's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is AKTX Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare AKTX vs AGIO

See how AKTX stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

How has AKTX stock performed recently?

AKTX declined -72.9% over the past year, below its 5-year annualized CAGR of -67.7%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is AKTX's all-time high price?

Akari Therapeutics, Plc reached $934.00 on 2015-08-20. The 52-week high is $1.73. Current 1-year return of -72.9% places the stock further from historical peaks.

Where can I download AKTX historical price data?

This page provides AKTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.
Showing 438 data points (sampled from 3,056)